Not yet recruitingNot a drug-phase studyRelapsing and progressiveNCT07193602

What it found

Still running

No result yet.

What was tested

Treatment tested

  • VR-based dexterity training in MS

Placebo or sham

  • mediation program

What it measured

Main measures

  • Arm Function Score in Multiple Sclerosis Questionnaire

    4 weeks

    Arm and hand function

Other measures (5)

  • Time for completing the Nine-hole-Peg-Test (9HPT)

    4 weeks

    Disability progressionArm and hand function
  • Time for completion the Coin rotation task (CRT)

    4 Weeks

    Arm and hand function
  • The highest strength value resulting from the Handheld JAMAR dynamometer

    4 Weeks

    Arm and hand functionPhysical function
  • Value resulting from the Multiple Sclerosis Impact Scale 29 (MSIS 29)

    4 Weeks

    Quality of life (reported by participants)
  • Scores of the Electronic Neurostatus-Expanded Disability Status Scale (eEDSS) (D'Souza M et al. 2020)

    4 Weeks

    Disability progressionArm and hand function

Who could take part

Relapsing and progressive · 18 to 75

Inclusion Criteria: * MS patients with relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS) or primary progressive MS (PPMS) according to the revised McDonald's criteria (Thompson et al. 2017) * Age between 18 and 75 years * Written informed consent signed by the subject must be obtained prior to study start * Patient must complain about MS related impaired manual dexterity negatively affecting ADL and/or QoL * Patients must have Arm function in multiple sclerosis questionnaire (AMSQ) score >41 Exclusion Criteria: * A relapse that started within 60 days prior to screening * Rapidly progressive disease * Any disease/condition that impaired manual dexterity besides MS * Any disease other than MS that could possibly explain the patient's signs and symptoms * Medical or psychiatric conditions that compromise the ability to comply with the protocol, or to complete the study * History of epilepsy or epileptic seizures * A history of drug abuse in the 12 months prior to screening

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

The aim of the study is to investigate if a specifically developed home-based dexterity training intervention using a Virtual Reality (VR) Headset (Meta quest 2) improves impaired manual dexterity in persons with multiple sclerosis.

Papers

Loading reviews and guidelines…

History

    1. Started

      May 2026

    2. Main results due

      May 2028

    3. Finished

      May 2028

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error